Evidence map›Paper›PMID 32894261›Full record

ArticleJournal of visualized experiments : JoVE2020

The Ago2-miRNA-co-IP Assay to Study TGF- β1 Mediated Recruitment of miRNA to the RISC in CFBE Cells.

Nilay Mitash, Joshua E Donovan, Agnieszka Swiatecka-Urban

Open access · greenAbstract readVideo-Audio Media
In one paragraph

Article in Journal of visualized experiments : JoVE, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Nilay MitashDepartment of Pediatrics, UPMC Children's Hospital of Pittsburgh, University of Pittsburgh School of Medicine; Department of Medicine, Division of Pulmonary, Allergy and Critical Care Medicine, 200 Lothrop Street, University of Pittsburgh, Pittsburgh, PA, 15261; NIM109@pitt.edu.
Joshua E DonovanDepartment of Pediatrics, UPMC Children's Hospital of Pittsburgh, University of Pittsburgh School of Medicine; Department of Pediatric Nephrology, University of Virginia, Charlottesville, VA, 22908.
Agnieszka Swiatecka-UrbanDepartment of Pediatrics, UPMC Children's Hospital of Pittsburgh, University of Pittsburgh School of Medicine; Department of Pediatric Nephrology, University of Virginia, Charlottesville, VA, 22908.
University of Pittsburgh · USUniversity of Virginia · US

Funding

Regulation of the Endocytic Trafficking of CFTRR01HL090767 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI SWIATECKA-URBAN, AGNIESZKA · 2008 to 2012
$2.2M
Correcting Pathogenic TGF beta Activity in the AirwayR01HL144539 · NHLBI · UNIVERSITY OF VIRGINIA · PI SWIATECKA-URBAN, AGNIESZKA · 2019 to 2022
$1.7M
Novel Pathways in TGF BETA SignalingR56HL127202 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI SWIATECKA-URBAN, AGNIESZKA · 2016 to 2016
$352k
NHLBI NIH HHS R01 HL090767NHLBI NIH HHS R01 HL144539NHLBI NIH HHS R56 HL127202
6 · The paper itself

Abstract

Micro(mi)RNAs are short, non-coding RNAs that mediate the RNA interference (RNAi) by post-transcriptional mechanisms. Specific miRNAs are recruited to the cytoplasmic RNA induced silencing complex (RISC). Argonaute2 (Ago2), an essential component of RISC, facilitates binding of miRNA to the target-site on mRNA, followed by cleaving the miRNA-mRNA duplex with its endonuclease activity. RNAi is mediated by a specific pool of miRNAs recruited to RISC, and thus is referred to as the functional pool. The cellular levels of many miRNAs are affected by the cytokine Transforming Growth Factor-β1 (TGF-β1). However, little is known about whether the TGF-β1 affects the functional pools of these miRNAs. The Ago2-miRNA-co-IP assay, discussed in this manuscript, is designed to examine effects of TGF-β1 on the recruitment of miRNAs to RISC and it helps to determine whether changes in the cellular miRNA levels correlate with changes in the RISC-associated, functional pools. The general principles of the assay are as follows. Cultured cells treated with TGF-β1 or vehicle control are lysed and the endogenous Ago2 is immunoprecipitated with immobilized anti-Ago2 antibody, and the active miRNAs complexed with Ago2 are isolated with a RISC immunoprecipitation (RIP) assay kit. The miRNAs are identified with quantitative reverse-transcriptase polymerase chain reaction (qRT-PCR) using miRNA-specific stem-looped primers during reverse transcription, followed by PCR using miRNA-specific forward and reverse primers, and TaqMan hydrolysis probes.

Indexed as

Argonaute ProteinsCells, CulturedHumansImmunoprecipitationMicroRNAsRNA-Induced Silencing ComplexTransforming Growth Factor beta1AGO2 protein, humanArgonaute ProteinsMicroRNAsRNA-Induced Silencing ComplexTransforming Growth Factor beta1

Identifiers

PMID32894261
PMCPMC8637178
OpenAlexW3082938399

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.